Prognostic significance of IKZF1 alterations in B-cell precursor ALL
Josep-Maria Ribera • 26 Jun 2020
Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
Petra Langerbeins • 16 Sep 2016
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.